Author

S. Göttig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:bacteria (other)· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:chromatin & epigenetic regulation· 1 Approach:comparative / phylogenetic analysis· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

M. Tietgen· 2 shared A. Brauer· 1 shared A. Mateus· 1 shared A. Milanese· 1 shared A. R. Brochado· 1 shared A. Typas· 1 shared B. Averhoff· 1 shared C. Cluzel· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. Tietgen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Domain-architecture aware phylogenetic profiling indicates a functional diversification of type IVa pili in the nosocomial pathogen Acinetobacter baumannii

R. Iruegas, K. Pfefferle, S. Göttig, B. Averhoff, I. Ebersberger

This study uses domain-architecture aware phylogenetic profiling to show that type IVa pili in Acinetobacter baumannii have diversified in domain structure, contributing to virulence and host interaction differences.

bioRxiv · Feb 1, 2023 · PreprintMicrobiology

Repurposing of the antibiotic nitroxoline for the treatment of mpox

D. Bojkova, N. Zoeller, M. Tietgen, K. Steinhorst, M. Bechtel, T. Rothenburger, J. D. Kandler, J. Schneider, V. M. Corman, S. Ciesek, H. F. Rabenau, M. N. Wass, S. Kippenberger, S. Göttig, M. Michaelis, J. Cinatl

This study shows nitroxoline, an antibiotic, inhibits mpox virus replication and remains effective against tecovirimat-resistant strains, suggesting it as a repurposing candidate for mpox treatment.

bioRxiv · Dec 29, 2022Microbiology

High-throughput profiling of drug interactions in Gram-positive bacteria

E. Cacace, V. Kim, M. Knopp, M. Tietgen, A. Brauer, K. Inecik, A. Mateus, A. Milanese, M. Torrissen Marli, K. Mitosch, J. Selkrig, A. R. Brochado, O. Kuipers, M. Kjos, G. Zeller, , A. Typas

This study systematically tests drug combinations in Gram-positive bacteria, identifying many new synergies and antagonisms, including effective combinations against drug-resistant strains.

bioRxiv · Dec 23, 2022 · PreprintMicrobiology

Incidence of an intracellular multiplication niche amongst Acinetobacter baumannii clinical isolates

T. Rubio, S. Gagne, C. Debruyne, C. Dias, C. Cluzel, D. Mongellaz, P. Rousselle, S. Göttig, H. Seifert, P. G. Higgins, S. P. Salcedo

This study identifies an intracellular multiplication niche in some Acinetobacter baumannii clinical isolates, enabling prolonged survival and antibiotic resistance.

bioRxiv · Apr 15, 2021Microbiology